HMN 2026: How Real-time brain monitor detects infections earlier
HMN 2026: How Seven-second X-ray scan detects severity of heart valve regurgitation in patients with repaired congenital heart defects
HMN 2026: How RAS(ON) inhibitor doubles median overall survival in patients with metastatic pancreatic cancer
HMN 2026: How Rare wild goats in Northumberland prove to be a genetically distinct breed
HMN 2026: How Novel radiopharmaceutical therapy offers powerful treatment option for aggressive neuroendocrine tumors
An example of partial response. 58-year-old patient with neuroendocrine neoplasm of the pancreas with hepatic and bone metastases. Previously treated with chemotherapy, hemithyroidectomy, PRRT with 177Lu-DOTATATE, Lanreotide, Everolimus, trans-arterial chemo-embolization of liver metastases.Credit: SNMMI. A new type of peptide receptor…
HMN 2026: How Guide contains quality standards for routinely collected health data in research
HMN 2026: Why do telomeres shorten when a cell divides, and how does it affect human aging?
HMN 2026: Why scientists are studying a microbe they found in a sink
HMN 2026: How approval processes drive up housing costs in major cities
HMN 2026: Why ‘psychopath’ is a dangerous label when it comes to criminal justice
HMN 2026: How Psychological course could be support for caregivers of people with dementia
HMN 2026: How PSMA PET reveals bone metastases missed by standard imaging
HMN 2026: How Psilocybin is linked to reduction in depression
A study of 19 patients with treatment-resistant depression treated with psilocybin in Switzerland found psilocybin was associated with a significant reduction in depression symptoms. The study is published in The Lancet Regional Health—Europe. Psilocybin—a naturally occurring psychedelic compound found in…
HMN 2026: How Novel prostate cancer treatment can reduce risk of disease progression by half
HMN 2026: How Study of prostate cancer in Brazil reveals racial inequalities in diagnosis and treatment
HMN 2026: How Dust-prone desert of the Southwest may be ideal for solar energy
HMN 2026: What is the price of winning at all costs—well-being in high-performance sport
HMN 2026: How Potentially reversible ALS mechanism changes understanding of the disease
HMN 2026: What are the Potential sources of a low-frequency sound
HMN 2026: What are the potential problems of living longer: Q&A
HMN 2026: What is the Potential gene therapy for late-stage Parkinson’s side-effects
Antagonism of A2aR and knockdown of GluN2B-NMDARs in iSPNs attenuate LID behaviors. Credit: Neuron (2026). DOI: 10.1016 Northwestern Medicine scientists have discovered that suppressing excitatory synaptic transmission in a small group of neurons in the brain may reverse levodopa-induced dyskinesia…
HMN 2026: How Popular GLP-1 drug may slow down biological aging
Glucagon-like peptide-1 (GLP-1) receptor agonist medications have gained widespread attention for effectively treating obesity, lowering blood sugar and decreasing the risk of cardiovascular disease. Some researchers have proposed that these drugs may also influence the biology of aging, but direct…
HMN 2026: How Poor sleep, night shift work is linked to higher risk of osteoarthritis
HMN 2026: How Poor sleep in middle-aged women is associated with lower psychological well-being nearly a decade later
HMN 2026: How Poor sleep health in adolescence is linked to hospitalization and worse health in young adulthood
HMN 2026: How Poop tests and blood tests join colonoscopy as options for colorectal cancer screening
HMN 2026: How The best pollinators can drive evolutionary changes in flowers
HMN 2026: How Political cues steer dating decisions, with cross-party matches often rejected by young Americans
HMN 2026: How Conductive plastic mimics heart cell ion signaling for first time
HMN 2026: What is the systems-based approach to prostate cancer screening decisions
HMN 2026: How Researchers use phylogenomics to identify cyanobacteria in Shenandoah River
HMN 2026: How Photoexcitation flips 2D moiré devices from metals to insulators in ultrafast test
HMN 2026: How Phone calls from a pharmacist could help people achieve healthy cholesterol
HMN 2026: How PFAS leave fingerprints in your blood—researchers are beginning to read these clues
HMN 2026: How PET imaging tracks whole-body metabolic changes after bariatric surgery
Representative whole-body PET/CT based organ and tissue segmentation before and 12 months after bariatric surgery in a 20-year-old woman. Coronal PET/CT images and automated segmentation maps show multi-organ structural remodeling, including reductions in subcutaneous adipose tissue, visceral adipose tissue, liver,…
HMN 2026: How PET imaging reveals synaptic loss in multiple sclerosis across preclinical and human studies
HMN 2026: How Integrated PET imaging platform rapidly defines clear margins to guide surgical resection in osteosarcoma
(A-C) Representative whole-body maximum-intensity projection images and regional fused PET/CT images from three histologically confirmed osteosarcoma patients who underwent paired [68Ga]Ga-B7-H3-BCH PET/CT and 18F-FDGE PET/CT within 7 days. (D) Multimodal imaging evaluation of patient 3, including X-ray, MRI (T2-weighted imaging,…
HMN 2026: How Perioperative apalutamide in high-risk localized or locally advanced prostate cancer reduces risk of metastasis, death
Credit: Anna Tarazevich from Pexels High-risk localized and locally advanced prostate cancer patients treated with apalutamide—a next generation neoadjuvant androgen-receptor pathway inhibitor (ARPI)—plus hormone therapy before and after prostate cancer surgery resulted in more major pathologic responses and reduced the…
